BioMarin's share prices fluctuate following Phase 3 clinical trial results

BioMarin Pharmaceutical (NASDAQ:BMRN) Inc., a California-based company specializing in therapies for severe and rare diseases, experienced significant fluctuations in its share prices on Monday. This volatility followed the release of data from a Phase 3 clinical trial of their experimental drug Roctavian.